Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Charcot-Marie-Tooth disease, type 1A - (AD) | 14.1 | | | Peripheral myelin protein 22
|
|
| | * Neuropathy, recurrent, with pressure palsies - HNPP | | * Dejerine-Sottas Syndrome - DSSB | | * Charcot-Marie-Tooth disease, type 1A - CMT1A | | * Charcot-Marie-Tooth disease, type 1E - CMT1E |
|
Charcot-Marie-Tooth disease, type 1B - (AD) | 14.2 | | | | * Charcot-Marie-Tooth disease, type 2I - CMT2I | | * Charcot-Marie-Tooth disease, type 2J - CMT2J | | * Charcot-Marie-Tooth disease, type 1B - CMT1B | | * Neuropathy, congenital hypomyelinating, 2 - CHN2 | | * Charcot-Marie-Tooth disease, dominant intermediate D - CMTDID | | * Dejerine-Sottas syndrome - DSSA |
|
Charcot-Marie-Tooth disease, type 1C - (AD) | 14.3 | | | Lipopolysaccharide-induced TNF factor
|
|
| | * Hereditary motor and sensory, type 1C - CMT1C |
|
Charcot-Marie-Tooth disease, type 1D - (AD) | 14.4 | | | Early growth response 2 protein
|
|
| | * Charcot-Marie-Tooth disease, type 1D - CMT1D | | * Charcot-Marie-Tooth neuropathy Type 4E - CMT4E | | * Dejerine-Sottas syndrome - DSS | | * Neuropathy, congenital hypomyelinating, 1 - CHN1 |
|
Charcot-Marie-Tooth disease, type 1E, with deafness - (AD) | 14.5 | | | Peripheral myelin protein 22
|
|
| | * Neuropathy, recurrent, with pressure palsies - HNPP | | * Dejerine-Sottas Syndrome - DSSB | | * Charcot-Marie-Tooth disease, type 1A - CMT1A | | * Charcot-Marie-Tooth disease, type 1E - CMT1E |
|
Hereditary Neuropathy with Liability to Pressure Palsies - (AD) | 14.6 | | | Peripheral myelin protein 22
|
|
| | * Neuropathy, recurrent, with pressure palsies - HNPP | | * Dejerine-Sottas Syndrome - DSSB | | * Charcot-Marie-Tooth disease, type 1A - CMT1A | | * Charcot-Marie-Tooth disease, type 1E - CMT1E |
|
Charcot-Marie-Tooth neuropathy Type 1F - (AD) | 14.7 | | | Neurofilament, light polypeptide 68kDa
|
|
| | * Charcot-Marie-Tooth disease, type 1F - CMT1F | | * Charcot-Marie-Tooth disease, type 2E - CMT2E | | * Charcot-Marie-Tooth disease, dominant intermediate G - CMTD1G |
|
Charcot-Marie Tooth disease, demyelinating type 1G - (AD) | 14.8 | | | peripheral myelin protein-2
|
|
| | * Charcot-Marie Tooth disease, demyelinating type 1G - CMT1G |
|
Charcot-Marie-Tooth neuropathy - (AD) | 14.9 | | | Polymerase III, RNA, Subunit B
|
|
| | * Charcot-Marie-Tooth neuropathy - CMT1I |
|
CMT with Congenital vertical talus - (AD) | 14.10 | | | | * Charcot-Marie-Tooth disease, congenital, vertical talus |
|
Slowed nerve conduction velocity - (AD) | 14.11 | | | Rho guanine nucleotide exchange factor 10
|
|
| | * Slowed nerve conduction velocity, autosomal dominant - NCV |
|
Neuropathy, hereditary, with or without age-related macular degeneration - (AD) | 14.12 | | | Fibulin 5 (extra-cellular matrix)
|
|
| | * Charcot-Marie-Tooth neuropathy, with fibulin defect |
|
Charcot-Marie-Tooth neuropathy - (AD) | 14.13 | | | Inositol 1,4,5-triphosphate receptor, type 3
|
|
| | * Charcot-Marie-Tooth neuropathy |
|
Charcot-Marie-Tooth disease, type 1, related to ATP1A1 - (AD) | 14.14 | | | ATPase, Na+/K+ transporting, alpha-1 polypeptide
|
|
| | * Charcot-Marie-Tooth disease, axonal, type 2DD - CMT2DD | | * Charcot-Marie-Tooth disease, type 1, related to ATP1A1 |
|
Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Charcot-Marie-Tooth disease, dominant intermediate A - (AD) | 14.15 | | | Golgi-specific brefeldin-A resistance factor 1
|
|
| | * Distal hereditary motor neuropathies | | * Charcot-Marie-Tooth disease, dominant intermediate A - CMT2GG |
|
Charcot-Marie-Tooth disease, dominant intermediate B - (AD) | 14.16 | | | | * Charcot-Marie-Tooth disease, dominant intermediate B - CMTDIB | | * Myopathy centronuclear, 1 - CNM1 | | * Lethal Congenital Contracture Syndrome 5 - LCCS5 |
|
Charcot-Marie-Tooth disease, dominant intermediate C - (AD) | 14.17 | | | | * Charcot-Marie-Tooth neuropathy, dominant intermediate C - CMTDIC |
|
Charcot-Marie-Tooth disease, dominant intermediate D - (AD) | 14.18 | | | | * Charcot-Marie-Tooth disease, type 2I - CMT2I | | * Charcot-Marie-Tooth disease, type 2J - CMT2J | | * Charcot-Marie-Tooth disease, type 1B - CMT1B | | * Neuropathy, congenital hypomyelinating, 2 - CHN2 | | * Charcot-Marie-Tooth disease, dominant intermediate D - CMTDID | | * Dejerine-Sottas syndrome - DSSA |
|
Charcot-Marie-Tooth disease, dominant intermediate E - (AD) | 14.19 | | | | * Charcot-Marie-Tooth neuropathy with glomerulopathy - CMTDIE |
|
Charcot-Marie-Tooth disease, dominant intermediate F - (AD) | 14.20 | | | Guanine nucleotidebinding protein, beta-4
|
|
| | * Charcot-Marie-Tooth neuropathy Type F - CMTD1F |
|
Charcot-Marie-Tooth disease, dominant intermediate G - (AD) | 14.21 | | | Neurofilament, light polypeptide 68kDa
|
|
| | * Charcot-Marie-Tooth disease, type 1F - CMT1F | | * Charcot-Marie-Tooth disease, type 2E - CMT2E | | * Charcot-Marie-Tooth disease, dominant intermediate G - CMTD1G |
|
Charcot-Marie Tooth disease, intermediate - (AD) | 14.22 | | | Cilia- and flagella-associated protein 276
|
|
| | * Charcot-Marie Tooth disease, intermediate |
|
Charcot-Marie-Tooth disease, recessive intermediate, A - (AR) | 14.23 | | | Ganglioside-induced differentiation-associated protein 1
|
|
| | * Charcot-Marie-Tooth disease, type 4A - CMT4A | | * Charcot-Marie-Tooth disease, mixed axonal and demyelinating type - CMT4A | | * Charcot-Marie-Tooth disease, type 2K - CMT2K | | * Charcot-Marie-Tooth disease, recessive intermediate, A - CMTRIA |
|
Charcot-Marie-Tooth disease, recessive intermediate, B - (AR) | 14.24 | | | | * Axonal neuropathy recessive - CMTRIB |
|
Charcot-Marie-Tooth disease, recessive intermediate, C - (AR) | 14.25 | | | Pleckstrin homology domain containing, family G (with RhoGef domain) member 5
|
|
| | * spinal muscular atrophy, distal, autosomal recessive, 4 - DSMA4 | | * Axonal neuropathy intermediate recessive C - CMTRIC |
|
Charcot-Marie-Tooth disease, recessive intermediate, D - (AR) | 14.26 | | | Cytochrome c oxidase subunit VIa polypeptide 1(M)
|
|
| | * CMT recessive intermediate D - CMTRID |
|
Charcot-Marie-Tooth disease, intermediate, related to SARS1 - (AD) | 14.27 | | | | * Charcot-Marie-Tooth disease, intermediate, related to SARS1 |
|
Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Charcot-Marie-Tooth disease Type 4A - (AR) | 14.28 | | | Ganglioside-induced differentiation-associated protein 1
|
|
| | * Charcot-Marie-Tooth disease, type 4A - CMT4A | | * Charcot-Marie-Tooth disease, mixed axonal and demyelinating type - CMT4A | | * Charcot-Marie-Tooth disease, type 2K - CMT2K | | * Charcot-Marie-Tooth disease, recessive intermediate, A - CMTRIA |
|
Charcot-Marie-Tooth disease Type 4B1 - (AR) | 14.29 | | | Myotubularin-related protein 2
|
|
| | * Charcot-Marie-Tooth disease, type 4B1 - CMT4B1 |
|
Charcot-Marie-Tooth disease Type 4B2 - (AR) | 14.30 | | | | * charcot-marie-tooth disease, type 4b2 - CMT4B2 |
|
Charcot-Marie-Tooth disease Type 4B3 - (AR) | 14.31 | | | | * Charcot-Marie-Tooth neuropathy Type 4B3 - CMT4B3 |
|
Charcot-Marie-Tooth disease, Type 4C - (AR) | 14.32 | | | | * Charcot-Marie-Tooth neuropathy Type 4F - CMT4C |
|
Charcot-Marie-Tooth disease, Type 4D (HMSN Lom, with deafness) - (AR) | 14.33 | | | N-myc downstream regulated gene 1
|
|
| | * Charcot-Marie-Tooth disease, type 4D - CMT4D | | * Neuropathy, hereditary motor and sensory, lom type - HMSNL | | * Hereditary motor and sensory neuropathy – Lom (with deafness) - HMNSL |
|
Neuropathy, congenital hypomyelinating, 1 - ( AR) | 14.34 | | | Early growth response 2 protein
|
|
| | * Charcot-Marie-Tooth disease, type 1D - CMT1D | | * Charcot-Marie-Tooth neuropathy Type 4E - CMT4E | | * Dejerine-Sottas syndrome - DSS | | * Neuropathy, congenital hypomyelinating, 1 - CHN1 |
|
Neuropathy, congenital hypomyelinating, 2 - ( AR) | 14.35 | | | | * Charcot-Marie-Tooth disease, type 2I - CMT2I | | * Charcot-Marie-Tooth disease, type 2J - CMT2J | | * Charcot-Marie-Tooth disease, type 1B - CMT1B | | * Neuropathy, congenital hypomyelinating, 2 - CHN2 | | * Charcot-Marie-Tooth disease, dominant intermediate D - CMTDID | | * Dejerine-Sottas syndrome - DSSA |
|
Charcot-Marie-Tooth disease, Type 4F - (AR) | 14.36 | | | | * Charcot-Marie-Tooth disease, type 4F - CMT4F | | * Dejerine-Sottas neuropathy, autosomal recessive - CMT4F |
|
Charcot-Marie-Tooth disease, Type 4G (type Russe) - (AR) | 14.37 | | | | * Charcot-Marie-Tooth neuropathy Type 4G - CMT4G |
|
Charcot-Marie-Tooth disease, Type 4H - (AR) | 14.38 | | | Actin-filament binding protein Frabin
|
|
| | * Charcot-Marie-Tooth neuropathy Type 4H - CMT4H |
|
Charcot-Marie-Tooth disease, Type 4J - (AR) | 14.39 | | | Sac domain-containing inositol phosphatase 3
|
|
| | * charcot-marie-tooth disease, type 4j - CMT4J | | * Amyotrophic lateral sclerosis 11 - ALS11 |
|
Charcot-Marie-Tooth disease, Type 4K - (AR) | 14.40 | | | | * Charcot-Marie-Tooth neuropathy Type 4K - CMT4K |
|
Charcot-Marie Tooth disease - (AR) | 14.41 | | | | * Charcot-Marie Tooth disease |
|
Charcot-Marie Tooth disease related to CNTNAP1 - (AR) | 14.42 | | | Contactin-Associated Protein 1
|
|
| | * Lethal congenital contracture syndrome 7 - LCCS7 | | * Charcot-Marie Tooth disease related to CNTNAP1 |
|
Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Charcot-Marie-Tooth neuropathy Type 2A1 - (AD) | 14.54 | | | Kinesin family member 1B(M)
|
|
| | * Charcot-Marie-Tooth disease, type 2A1 - CMT2A1 |
|
Charcot-Marie-Tooth neuropathy Type 2A2 - (AD) | 14.55 | | | | * Hereditary motor and sensory neuropathy 2A - CMT2A2A | | * Charcot-Marie-Tooth disease, axonal, type 2A2B - CMT2A2B | | * Hereditary motor and sensory neuropathy, type VIA with optic atrophy - HMSN6A |
|
Charcot-Marie-Tooth neuropathy Type 2B - (AD) | 14.56 | | | RAB7, member RAS oncogene family
|
|
| | * Charcot-Marie-Tooth neuropathy Type 2B - CMT2B |
|
Hereditary motor and sensory neuropathy, type IIC - (AD) | 14.57 | | | Transient receptor potential cation channel, subfamily V, member 4
|
|
| | * Scapuloperoneal spinal muscular atrophy - SPSMA | | * Neuronopathy, distal hereditary motor, type VIII - HMN8 | | * Spinal muscular atrophy congenital non progressive of lower limbs - SMAL | | * Spinal muscular atrophy, congenital benin, with contractures - SMAL |
|
Charcot-Marie-Tooth neuropathy Type 2D - (AD) | 14.58 | | | | * Neuropathy, distal hereditary motor type V - HMN V | | * Spinal muscular atrophy, distal, type V - DSMAV | | * Charcot-Marie-Tooth disease, axonal, type 2D - CMT2D |
|
Charcot-Marie-Tooth neuropathy Type 2E - (AD) | 14.59 | | | Neurofilament, light polypeptide 68kDa
|
|
| | * Charcot-Marie-Tooth disease, type 1F - CMT1F | | * Charcot-Marie-Tooth disease, type 2E - CMT2E | | * Charcot-Marie-Tooth disease, dominant intermediate G - CMTD1G |
|
Charcot-Marie-Tooth neuropathy Type 2F - (AD, AR) | 14.60 | | | Heat shock 27kDa protein 1
|
|
| | * Charcot-Marie-Tooth neuropathy Type 2F - CMT2F | | * Neuropathy, distal hereditary motor, type IIB - HMN2B |
|
Charcot-Marie-Tooth neuropathy Type 2H - (AD) | 14.61 | | | | * Charcot-Marie-Tooth neuropathy Type 2H - CMT2H |
|
Charcot-Marie-Tooth neuropathy Type 2I - (AD) | 14.62 | | | | * Charcot-Marie-Tooth disease, type 2I - CMT2I | | * Charcot-Marie-Tooth disease, type 2J - CMT2J | | * Charcot-Marie-Tooth disease, type 1B - CMT1B | | * Neuropathy, congenital hypomyelinating, 2 - CHN2 | | * Charcot-Marie-Tooth disease, dominant intermediate D - CMTDID | | * Dejerine-Sottas syndrome - DSSA |
|
Charcot-Marie-Tooth neuropathy Type 2J - (AD) | 14.63 | | | | * Charcot-Marie-Tooth disease, type 2I - CMT2I | | * Charcot-Marie-Tooth disease, type 2J - CMT2J | | * Charcot-Marie-Tooth disease, type 1B - CMT1B | | * Neuropathy, congenital hypomyelinating, 2 - CHN2 | | * Charcot-Marie-Tooth disease, dominant intermediate D - CMTDID | | * Dejerine-Sottas syndrome - DSSA |
|
Charcot-Marie-Tooth neuropathy Type 2K - (AD, AR) | 14.64 | | | Ganglioside-induced differentiation-associated protein 1
|
|
| | * Charcot-Marie-Tooth disease, type 4A - CMT4A | | * Charcot-Marie-Tooth disease, mixed axonal and demyelinating type - CMT4A | | * Charcot-Marie-Tooth disease, type 2K - CMT2K | | * Charcot-Marie-Tooth disease, recessive intermediate, A - CMTRIA |
|
Charcot-Marie-Tooth neuropathy Type 2L - (AD) | 14.65 | | | Heat shock 27kDa protein 8
|
|
| | * Neuropathy, distal hereditary motor, type II - HMN2A | | * Rimmed vacuole myopathy | | * Charcot-Marie-Tooth neuropathy Type 2L - CMT2L |
|
Charcot-Marie-Tooth neuropathy Type 2N - (AD) | 14.66 | | | | * Charcot-Marie-Tooth disease, axonal, type 2N - CMT2N |
|
Charcot-Marie-Tooth neuropathy Type 2O - (AD) | 14.67 | | | Dynein, cytoplasmic 1, heavy chain 1
|
|
| | * Charcot-Marie-Tooth disease, axonal, type 20 - CMT2O | | * Spinal muscular atrophy, lower extremity, autosomal dominant - SMALED |
|
Charcot-Marie-Tooth neuropathy Type 2P - (AD) | 14.68 | | | Leucine rich repeat and sterile alpha motif containing 1
|
|
| | * Charcot-Marie-Tooth neuropathy Type 2P - CMT2P |
|
Charcot-Marie-Tooth neuropathy Type 2Q - (AD) | 14.69 | | | Dehydrogenase E1 and transketolase domain containing 1(M)
|
|
| | * Charcot-Marie-Tooth neuropathy Type 2Q - CMT2Q |
|
Charcot-Marie-Tooth neuropathy Type 2U | 14.70 | | | Methionyl-tRNA synthetase
|
|
| | * Charcot-Marie-Tooth neuropathy Type 2U - CMT2U | | * Spastic paraplegia 70, autosomal recessive - SPG70 |
|
Charcot-Marie-Tooth neuropathy Type 2V - (AD) | 14.71 | | | N-acetyl-alpha-glucosaminidase
|
|
| | * Charcot-Marie-Tooth neuropathy Type 2V - CMT2V |
|
Charcot-Marie-Tooth neuropathy Type 2W - (AD) | 14.72 | | | | * Charcot-Marie-Tooth neuropathy Type 2W - CMT2W |
|
Charcot-Marie-Tooth neuropathy Type 2Y - (AD) | 14.73 | | | Valosin-containing protein
|
|
| | * Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 - IBMPFD1 | | * Inclusion body myopathy with early-onset paget disease and frontotemporal dement - IBMPFD | | * Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia - ALS14 | | * Scapuloperoneal muscular dystrophy and dropped head syndrome | | * Charcot-Marie-Tooth neuropathy Type 2Y - CMT2Y |
|
Charcot-Marie-Tooth neuropathy Type 2Z - (AD) | 14.74 | | | MORC family CW-type zinc finger 2
|
|
| | * Charcot-Marie-Tooth neuropathy Type 2Z - CMT2Z |
|
Charcot-Marie-Tooth disease, axonal, type 2CC - (AD) | 14.75 | | | Neurofilament, heavy polypeptide
|
|
| | * Susceptibility to amyotrophic lateral sclerosis related to NEFH - ALSDC | | * Charcot-Marie-Tooth disease, axonal, type 2CC - CMT2CC |
|
Charcot-Marie-Tooth disease, axonal, type 2DD - (AD) | 14.76 | | | ATPase, Na+/K+ transporting, alpha-1 polypeptide
|
|
| | * Charcot-Marie-Tooth disease, axonal, type 2DD - CMT2DD | | * Charcot-Marie-Tooth disease, type 1, related to ATP1A1 |
|
Charcot-Marie-Tooth disease, axonal, type 2FF - (AD) | 14.77 | | | | * Charcot-Marie-Tooth disease, axonal, type 2FF - CMD2FF |
|
Hereditary motor and sensory neuropathy, Okinawa type - (AD) | 14.78 | | | | * Hereditary motor and sensory, neuropathy, proximal, type - HMSNP | | * Neuropathy, hereditary motor and sensory, Okinawa type - HMSNO | | * Spastic paraplegia 57, autosomal recessive - SPG57 |
|
Hereditary motor and sensory neuropathy, type VIA with optic atrophy - (AD) | 14.79 | | | | * Hereditary motor and sensory neuropathy 2A - CMT2A2A | | * Charcot-Marie-Tooth disease, axonal, type 2A2B - CMT2A2B | | * Hereditary motor and sensory neuropathy, type VIA with optic atrophy - HMSN6A |
|
CMT2 related to KIF5A - (AD) | 14.80 | | | | * Spastic paraplegia 10 - SPG10 | | * CMT2 related to KIF5A | | * Amyotrophic lateral sclerosis 25, susceptibility to - ALS25 |
|
Early onset axonal neuropathy with sensory ataxia - (AD) | 14.81 | | | Diacylglycerol O-acyltransferase 2
|
|
| | * Early onset axonal neuropathy with sensory ataxia |
|
Charcot-Marie-Tooth disease, axonal, related to BAG3 - (AD) | 14.82 | | | BCL2-associated athanogene 3
|
|
| | * myofibrillar myopathy with bag3 defect | | * Dilated cardiomyopathy related to BAG3 - CMD1HH | | * Charcot-Marie-Tooth disease, axonal, related to BAG3 |
|
Charcot-Marie-Tooth disease, axonal, related to JAG1 - (AD) | 14.83 | | | | * Charcot-Marie-Tooth disease, axonal, related to JAG1 - CMT2 |
|
Charcot-Marie-Tooth disease, axonal, related to NOTCH2NLC - (AD) | 14.84 | | | Notch2 N-terminal-like protein
|
|
| | * Neuronal intranuclear inclusion diseases - NIID | | * Oculopharyngodistal myopathy | | * Charcot-Marie-Tooth disease, axonal, related to NOTCH2NLC - CMT2 |
|
Charcot-Marie-Tooth disease, axonal, related to CRYAB - (AD) | 14.85 | | | | * Dilated cardiomyopathy related to alpha-crystallin | | * Myofibrillar myopathy, alpha-B crystallin related | | * Myopathy, myofibrillar, 2 - MFM2 | | * Charcot-Marie-Tooth disease, axonal, related to CRYAB - CMT2 |
|
Charcot-Marie-Tooth disease, axonal, related to DHX9 - (AD) | 14.86 | | | | * Charcot-Marie-Tooth disease, axonal, related to DHX9 - CMT2 |
|
Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Charcot-Marie-Tooth disease, axonal, type 2A2B - (AR) | 14.87 | | | | * Hereditary motor and sensory neuropathy 2A - CMT2A2A | | * Charcot-Marie-Tooth disease, axonal, type 2A2B - CMT2A2B | | * Hereditary motor and sensory neuropathy, type VIA with optic atrophy - HMSN6A |
|
Charcot-Marie-Tooth disease, axonal, type 2B1 - (AR) | 14.88 | | | | * Charcot-Marie-Tooth disease, axonal, type 2B1 - CMT2B1 | | * Hutchinson-Gilford progeria syndrome - HGPS | | * Mandibuloacral dysplasia with type a lipodystrophy - MADA | | * restrictive dermopathy | | * Lipodystrophy, familial partial, type 2 - FPLD2 | | * Cardiomyopathy, dilated, 1A - CMD1A | | * Congenital muscular dystrophy due to LMNA defect (L-CMD) | | * Emery-Dreifuss muscular dystrophy, autosomal dominant - EDMD2 | | * Emery-Dreifuss Autosomal recessive - EDMD3 | | * Muscular dystrophy, limb-girdle, type 1B - LGMD1B |
|
Charcot-Marie-Tooth disease, axonal, type 2B2 - (AR) | 14.89 | | | polynucleotide kinase 3’-phosphatase
|
|
| | * Charcot-Marie-Tooth disease, type 2B2 - CMT2B2 | | * Early-onset axonal Charcot-Marie-Tooth with ataxia |
|
Charcot-Marie-Tooth disease, axonal, type 2EE - (AR) | 14.90 | | | MpV17 mitochondrial inner membrane protein(M)
|
|
| | * Charcot-Marie-Tooth disease, axonal, type 2EE - CMT2EE |
|
Autosomal recessive CMT2 related to DNAJB2 - (AR) | 14.91 | | | DnaJ (Hsp40) homolog, subfamily B, member 2
|
|
| | * Spinal muscular atrophy, distal related to DNAJB2 | | * Spinal muscular atrophy, distal, autosomal recessive, 5 - DSMA5 | | * Autosomal recessive CMT2 related to DNAJB2 |
|
Neuromyotonia and axonal neuropathy, autosomal recessive - (AR) | 14.92 | | | Histidine triad nucleotide binding protein 1
|
|
| | * Neuromyotonia and axonal neuropathy, autosomal recessive - NMAN | | * Neuronopathy, Distal hereditary motor related to HINT1 |
|
Charcot-Marie-Tooth disease, type 2R - (AR) | 14.93 | | | Tripartite motif containing 2
|
|
| | * Charcot-Marie-Tooth neuropathy Type 2R - CMT2R |
|
Charcot-Marie-Tooth disease, type 2S - (AR) | 14.94 | | | Immunoglobulin mu binding protein 2
|
|
| | * Spinal muscular atrophy with respiratory distress - SMARD1 | | * Autosomal recessive CMT axonal type 2S - CMT2S |
|
Charcot-Marie-Tooth disease, type 2T - (AR) | 14.95 | | | Membrane metallo-endopeptidase
|
|
| | * Charcot-Marie-Tooth neuropathy Type 2T - CMT2T | | * Spinocerebellar Ataxia, type 43 - SCA43 |
|
Charcot-Marie-Tooth disease, type 2X - (61) | 14.96 | | | SPG11 vesicle trafficking associated, Spatacsin
|
|
| | * Spastic paraplegia 11 - SPG11 | | * Charcot-Marie-Tooth neuropathy Type 2X - CMT2X | | * Amyotrophic lateral sclerosis 5 - ALS5 |
|
Early-onset axonal Charcot-Marie-Tooth with ataxia - (AR) | 14.97 | | | polynucleotide kinase 3’-phosphatase
|
|
| | * Charcot-Marie-Tooth disease, type 2B2 - CMT2B2 | | * Early-onset axonal Charcot-Marie-Tooth with ataxia |
|
Charcot-Marie-Tooth disease, axonal - (AR) | 14.98 | | | Sphingosine-1-Phosphate Lyase 1
|
|
| | * Charcot-Marie-Tooth disease, axonal |
|
Charcot-Marie-Tooth disease, axonal, related to SCO2 - (AR) | 14.99 | | | Cytochrome c oxidase assembly protein(M)
|
|
| | * Mitochondrial complex IV deficiency, nuclear type 2 - MC4DN2 (CEMCOX1) | | * Charcot-Marie-Tooth disease, axonal, related to SCO2 |
|
Charcot-Marie-Tooth disease, axonal; related to SACS - (AR) | 14.100 | | | | * Autosomal recessive spastic ataxia of Charlevoix-Saguenay - ARSACS | | * Charcot-Marie-Tooth disease, axonal; related to SACS | | * Spastic ataxia, Charlevoix-Saguenay type - SACS | | * Spastic ataxia Charlevoix-Saguenay type - SPAX6 |
|
Sorbitol dehydrogenase deficiency with peripheral neuropathy (CMT2 AR) - (AR) | 14.101 | | | | * Sorbitol dehydrogenase deficiency with peripheral neuropathy - SORDD | | * Neuropathy, hereditary motor, autosomal recessive 8 - HMNR8 |
|
Charcot-Marie-Tooth disease, axonal - (AR) | 14.102 | | | Minichromosome maintenance 3-associated protein
|
|
| | * Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development - PNRIID | | * Charcot-Marie-Tooth disease, axonal |
|
Charcot-Marie-Tooth disease, axonal - (AR) | 14.103 | | | Beta-1,4-N-acetyl-galactosaminyl transferase 1
|
|
| | * Spastic paraplegia 26 - SPG26 | | * Charcot-Marie-Tooth disease, axonal |
|
Charcot-Marie-Tooth disease, axonal - (AR) | 14.104 | | | | * Charcot-Marie-Tooth disease, axonal |
|
Progressive neuropathy - (AR) | 14.105 | | | Phosphoserine Aminotransferase 1
|
|
| |
Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Hereditary sensory and autonomic neuropathy, type IA - (AD) | 14.106 | | | Serine palmitoyltransferase subunit 1
|
|
| | * Neuropathy, hereditary sensory, type 1 - HSN1 | | * Neuropathy, hereditary sensory and autonomic, type 1 - HSAN1 | | * Amyotrophic lateral sclerosis |
|
Hereditary sensory and autonomic neuropathy type IB with cough and gastroesophageal reflux - (AD) | 14.107 | | | | * hereditary sensory and autonomic neuropathy type ib with cough and gastroesophag - HSAN1B |
|
Hereditary sensory and autonomic neuropathy, type IC - (AD) | 14.108 | | | Serine palmitoyltransferase long chain base subunit 2
|
|
| | * Neuropathy, hereditary sensory and autonomic, type IC - HSAN1C |
|
Hereditary sensory and autonomic neuropathy type IIA - (AR) | 14.109 | | | WNK lysine deficient protein kinase 1
|
|
| | * neuropathy, hereditary sensory and autonomic, type iia - HSAN2 |
|
Hereditary sensory and autonomic neuropathy type IIB - (AR) | 14.110 | | | Family with sequence similarity 134 member B
|
|
| | * Hereditary sensory neuropathy, type IIB - HSAN2B |
|
Neuropathy, hereditary sensory and autonomic, type IID - (AR) | 14.111 | | | Sodium voltage-gated channel alpha subunit 9
|
|
| | * Neuropathy, hereditary sensory and autonomic, type IID - HSAN2D | | * Erythromelalgia, Primary - SFNP |
|
Hereditary sensory and autonomic neuropathy type III - (AR) | 14.112 | | | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein
|
|
| | * Neuropathy, hereditary sensory and autonomic, type III - HSAN3 | | * Familial dysautonomia (Riley-Day syndrome) |
|
Hereditary sensory and autonomic neuropathy type IV - (AR) | 14.113 | | | neurotrophic receptor tyrosine kinase 1
|
|
| | * Hereditary sensory and autonomic neuropathy type IV - HSAN4 |
|
Hereditary sensory and autonomic neuropathy type V - (AR) | 14.114 | | | Nerve growth factor (beta polypeptide)
|
|
| | * neuropathy, hereditary sensory and autonomic type v - HSAN5 |
|
Hereditary sensory and autonomic neuropathy type VI - (AR) | 14.115 | | | | * Hereditary sensory and autonomic neuropathy type VI - HSAN6 |
|
Neuropathy, hereditary sensory and autonomic, type VII - (AD) | 14.116 | | | Sodium voltage-gated channel alpha subunit 11
|
|
| | * Neuropathy, hereditary sensory and autonomic, type VII - HSAN7 | | * Episodic pain syndrome, familial 3 - FEPS3 |
|
Hereditary sensory and autonomic neuropathy type VIII - (AR) | 14.117 | | | PR/SET domain 12 (positive regulatory domain zinc finger protein 12)
|
|
| | * Hereditary sensory and autonomic neuropathy type VIII - HSAN8 |
|
Hereditary sensory neuropathy type ID - (AD) | 14.118 | | | | * Neuropathy, hereditary sensory, type ID - HSN1D | | * Spastic paraplegia 3, autosomal dominant (Strumpell disease) - SP3A |
|
Hereditary sensory neuropathy type IE - (AD) | 14.119 | | | DNA (cytosine-5)-methyltransferase 1
|
|
| | * Neuropathy, hereditary sensory, type 1E - HSN1E | | * Hereditary sensory neuropathy with dementia and hearing loss |
|
Neuropathy, hereditary sensory, type IF - (AD) | 14.120 | | | | * Hereditary sensory neuropathy type IF - HSN IF |
|
Hereditary sensory neuropathy, type IIC - (AD) | 14.121 | | | | * Neuropathy, hereditary sensory, type IIC - HSN2C | | * Spastic paraplegia 30 - SPG30 |
|
Ataxia, posterior column, with retinitis pigmentosa (PCARP) - (AR) | 14.122 | | | Feline leukemia subgroup C receptor 1
|
|
| | * Ataxia, posterior column, with retinitis pigmentosa (PCARP) - AXPC1 |
|
Absence of pain, Congenital - (AR) | 14.123 | | | Clathrin, heavy polypeptide-like 1
|
|
| | * Absence of pain, Congenital |
|
Marssili syndrome (insensitivity to pain, congenital, AD) - (AD) | 14.124 | | | | * Marssili syndrome (insensitivity to pain, congenital, AD) - MARSIS |
|
Erythromelalgia, Primary - (AD) | 14.125 | | | Sodium voltage-gated channel alpha subunit 9
|
|
| | * Neuropathy, hereditary sensory and autonomic, type IID - HSAN2D | | * Erythromelalgia, Primary - SFNP |
|
Episodic pain syndrome, familial 3 - (AD) | 14.126 | | | Sodium voltage-gated channel alpha subunit 11
|
|
| | * Neuropathy, hereditary sensory and autonomic, type VII - HSAN7 | | * Episodic pain syndrome, familial 3 - FEPS3 |
|
Polyneuropathy with erythromelalgia - (AR) | 14.127 | | | Nicotinamide nucleoside adenyltransferase 2
|
|
| | * Polyneuropathy with erythromelalgia |
|
Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome - (AR) | 14.128 | | | Replication Factor C Subunit 1
|
|
| | * Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome - CANVAS |
|
Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Peripheral neuropathy and agenesis of the corpus callosum (Charlevoix disease) - (AR) | 14.129 | | | Potassium chloride cotransporter KCC3
|
|
| | * Agenesis of the corpus callosum with peripheral neuropathy - ACCPN | | * Charlevoix disease - SLC12A6 | | * Andermann syndrome - SLC12A6 |
|
Peripheral neuropathy and deafness, autosomal dominant - (AD) | 14.130 | | | Gap junction protein, beta 3, 31kDa (=connexin 31)
|
|
| | * Peripheral neuropathy and deafness, autosomal dominant |
|
Hereditary neuralgic amyotrophy (familial brachial plexus neuropathy) - (AD) | 14.131 | | | | * Familial brachial plexus neuropathy - HNA |
|
Giant axonal neuropathy-1 - (AR) | 14.132 | | | | * Giant axonal neuropathy-1 - GAN1 |
|
Giant axonal neuropathy-2 - (AD) | 14.133 | | | DDB1 and CUL4 associated factor 8
|
|
| | * Giant axonal neuropathy 2 - GAN2 |
|
Congenital cataracts, facial dysmorphism and neuropathy - (AR) | 14.134 | | | CTD phosphatase subunit 1
|
|
| | * congenital cataracts, facial dysmorphism, and neuropathy - CCFDN |
|
Complex motor and sensory axonal neuropathy plus microcephaly and cerebral dysgenesis - (AR) | 14.135 | | | Vaccinia related kinase 1
|
|
| | * Pontocerebellar hypoplasia type 1 - PCH1 | | * Complex motor and sensory axonal neuropathy plus microcephaly and cerebral dysge | | * Spinal muscular atrophy, distal, autosomal recessive - DSMA |
|
Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive - (AR) | 14.136 | | | Chaperonin containing TCP1 subunit 5
|
|
| | * Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive |
|
Neuronal intranuclear inclusion diseases - (AD) | 14.137 | | | Notch2 N-terminal-like protein
|
|
| | * Neuronal intranuclear inclusion diseases - NIID | | * Oculopharyngodistal myopathy | | * Charcot-Marie-Tooth disease, axonal, related to NOTCH2NLC - CMT2 |
|
Hereditary peripheral neuropathy (CMT ?) - (AD) | 14.138 | | | Solute carrier family 9, member 3, regulator 1
|
|
| | * Hereditary peripheral neuropathy |
|
Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities - (AR, AD) | 14.139 | | | Asparaginyl-tRNA Synthetase 1
|
|
| | * Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities - NEDMILG |
|
Myopathy, Congenital, With Neuropathy And Deafness - (AR) | 14.140 | | | Spectrin, Beta, Nonerythrocytic, 4
|
|
| | * Myopathy, Congenital, With Neuropathy And Deafness - CMND |
|